(Q45011976)

English

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 December 2017

Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure (English)

1 reference

Europe PubMed Central

8 December 2017

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

Aldo P. Maggioni

5

1 reference

Europe PubMed Central

8 December 2017

1

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

8 December 2017

author name string

Gianni Tognoni

2

1 reference

Europe PubMed Central

8 December 2017

Maria Grazia Franzosi

3

1 reference

Europe PubMed Central

8 December 2017

Roberto Latini

4

1 reference

Europe PubMed Central

8 December 2017

Roberto Marchioli

6

1 reference

Europe PubMed Central

8 December 2017

Gian Luigi Nicolosi

7

1 reference

Europe PubMed Central

8 December 2017

Maurizio Porcu

8

1 reference

Europe PubMed Central

8 December 2017

GISSI-HF Investigators

9

1 reference

Europe PubMed Central

8 December 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

8 December 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

8 December 2017

6

1 reference

Europe PubMed Central

8 December 2017

5

1 reference

Europe PubMed Central

8 December 2017

635-641

1 reference

Europe PubMed Central

8 December 2017

The Denolin lecture. Congestive heart failure: a half century perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

n-3 polyunsaturated fatty acids and cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Molecular and genetic aspects of cardiac fatty acid homeostasis in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Endothelial dysfunction in human disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

The endotoxin-lipoprotein hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Statins and chronic heart failure: do we need a large-scale outcome trial?

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

n-3 Polyunsaturated Fatty Acids, Fish, and Nonfatal Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2004.03.001

21 January 2018

Identifiers

10.1016/J.EJHEART.2004.03.001

1 reference

Europe PubMed Central

8 December 2017

1 reference

Europe PubMed Central

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45011976&oldid=2067456134"